3 years ago

Epoch Biodesign Secures $11M Seed Funding to Advance Biorecycling

  • Epoch Biodesign, a London, UK-based Total BioDesignTM Company, raised $11M in seed funding led by Lowercarbon Capital

  • The company intends to use the funds for the expansion of its protein design platform, construction of new R&D facilities, and further development and scale up of their first solution

  • Epoch Biodesign is developing natural solutions for unnatural problems with the mission to scale and industrialize biology for a healthy planet

  • They are advancing biorecycling: a tuneable enzymatic process to transform plastic waste into everyday chemicals.

      • ProblemBiotechnology

      "Epoch Biodesign is trying to solve the problem of transforming plastic waste into everyday chemicals through biorecycling, a process that uses enzymes to break down plastics."

      Solution

      "The company is developing a platform that uses computational and experimental tools to design proteins that can break down plastics efficiently, thus offering a natural solution to the problem of plastic waste."

      Covered on